Center for Renal Translational Medicine

Publications


2016

2015

2014

2013

2012

2011


2010

2009

  • TGF-ß inhibits Ang II-induced MAPK signaling in vascular smooth muscle cells through downregulation of Ang II type 1 receptors. Meijering, B. Els A. van der Wouden, Vincent Pelgröm, Robert H. Henning, Kumar Sharma, and Leo E. Deelman. Journal of Vascular Research, 10:459-468, 2009
  • Burnt-out diabetes: impact of chronic kidney disease progression on the natural course of diabetes mellitus. Kalantar-Zadeh K, Derose SF, Nicholas S, Benner D, Sharma K, Kovesdy CP. J Ren Nutr. 2009 Jan;19(1):33-7
  • Mechanisms of kidney fibrosis and the role of antifibrotic therapies. Deelman L, Sharma K. Curr Opin Nephrol Hypertens. 2009 Jan;18(1):85-90.
  • Renal sodium-glucose transport: role in diabetes mellitus and potential clinical implications. Bakris GL, Fonseca VA, Sharma K, Wright EM. Kidney Int. 2009 Jun;75(12):1272-7.
  • Moderate exercise attenuates caspase-3 activity, oxidative stress, and inhibits progression of diabetic renal disease in db/db mice. Sanjoy Ghosh, Majid Khazaei, Farzad Moien Afshari, Lisa S. Ang, David J. Granville, Bruce Verchere, Stephen R. Dunn, Peter McCue, Andrew Mizisin, Kumar Sharma, and Ismail Laher. Am J Physiol Renal Physiol 2009 Apr;296(4):F700-8.
  • Transcription factors in the pathogenesis of diabetic nephropathy. Sanchez AP, Sharma K. Expert Rev Mol Med. 2009 Apr 28;11:e13.
  • The Link between Obesity and Albuminuria: Adiponectin and Podocyte Dysfunction. Sharma K. Kidney Int. 2009 Jul;76(2):145-8. Epub 2009 Apr 29.
  • Pirfenidone Is Renoprotective in Diabetic Kidney Disease. Ramachandrarao SP, Zhu Y, Ravasi T, McGowan TA, Toh I, Dunn SR, Okada S, Shaw MA, Sharma K. J Am Soc Nephrol. 2009 Aug;20(8):1765-75. Epub 2009 Jul 2
  • Mouse Models of Diabetic Nephropathy. Brosius FC 3rd, Alpers CE, Bottinger EP, Breyer MD, Coffman TM, Gurley SB, Harris RC, Kakoki M, Kretzler M, Leiter EH, Levi M, McIndoe RA, Sharma K, Smithies O, Susztak K, Takahashi N, Takahashi T; for the Animal Models of Diabetic Complications Consortium. J Am Soc Nephrol 2009 Dec;20(12):2503-12.

  • 2008



    Conference Presentations


    ASN Kidney Week Conference 2014

  • Mitochondria and Metabolomics in Diabetic Complications
    Time: 3:12pm - 3:36pm
    Speaker: Kumar Sharma

  • Session - Role of Reactive Oxygen Species in Diabetic Nephropathy
    Type: Basic and Clinical Science Symposium
    Date: Sunday, November 16, 2014
    Time: 10:00am - 12:00pm
    Moderator: Kumar Sharma

  • Restoring Mitochondrial Superoxide Levels with BendaviaTM Protects Against Progression of Diabetic Kidney Disease in db/db Mice
    Speaker: Satoshi Miyamoto
    Satoshi Miyamoto, Manjula Darshi, Larkin B. Slater, Tai Nguyen, Peter J. Oates and Kumar Sharma. Center for Renal Translational Medicine, University of California, San Diego, La Jolla, CA, United States; Veterans Administration San Diego HealthCare System, La Jolla, CA, United States and Stealth Peptides, Inc., Newton, MA, United States.

  • Cholecystokinin Activates AMPK and Protects Against Progression of Diabetic Kidney Disease in db/db Mice
    Speaker: Satoshi Miyamoto
    Satoshi Miyamoto, Maggie K. Diamond-stanic, Manjula Darshi1, Tammy Quach1, Larkin B. Slater, and Kumar Sharma. Center for Renal Translational Medicine, University of California, San Diego, La Jolla, CA, United States and Veterans Administration San Diego HealthCare System, La Jolla, CA, United States.

  • High Spatial and Spectral Resolution Mass Spectrometry Imaging Reveals Reduced AMP and Elevated ATP Levels in Glomeruli of Diabetic Mice
    Speaker: Satoshi Miyamoto
    Satoshi Miyamoto, Gregory Hamm, Jonathan Stauber, Pieter Dorrestein, and Kumar Sharma. Institute of Metabolomic Medicine, University of California, San Diego, La Jolla, CA, United States; Center for Renal Translational Medicine, University of California, San Diego, La Jolla, CA, United States; Veterans Affairs San Diego Healthcare System, La Jolla, CA, United States; MS Imaging Department, ImaBiotech, Lille, France and Therapeutic Discovery Mass Spectrometry Center, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA, United States.

  • External Resources: